Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation

Open access

Abstract

Aims: High-density lipoprotein (HDL) function may be altered in patients with chronic disease, transforming the particle from a beneficial vasoprotective molecule to a noxious pro-inflammatory equivalent. Adolescents with Type 1 diabetes often have elevated HDL, but its vasoprotective properties and relationship to endothelial function have not been assessed. Methods and results: Seventy adolescents with Type 1 diabetes (age 10–17 years) and 30 age-matched healthy controls supplied urine samples for the measurement of early renal dysfunction (albumin:creatinine ratio; ACR), blood samples for the assessment of cardiovascular risk factors (lipid profiles, HDL functionality, glycaemic control, and inflammatory risk score), and had their conduit artery endothelial function tested using flow-mediated dilation (FMD). HDL-c levels (1.69 ± 0.41 vs. 1.44 ± 0.29mmol/L; P < 0.001), and glycated haemoglobin (HbA1c) (8.4 ± 1.2 vs. 5.4 ± 0.2%; P < 0.001) were increased in all patients compared with controls. However, increased inflammation and HDL dysfunction were evident only in patients who also had evidence of early renal dysfunction (mean ± standard deviation for high-ACR vs. low-ACR and healthy controls: inflammatory risk score 11.3 ± 2.5 vs. 9.5 ± 2.4 and 9.2 ± 2.4, P < 0.01; HDL-mediated nitric-oxide bioavailability 38.0 ± 8.9 vs. 33.3 ± 7.3 and 25.0 ± 7.7%, P < 0.001; HDL-mediated superoxide production 3.71 ± 3.57 vs. 2.11 ± 3.49 and 1.91 ± 2.47nmol O2 per 250 000 cells, P < 0.05). Endothelial function (FMD) was impaired only in those who had both a high inflammatory risk score and high levels of HDL-c (P < 0.05). Conclusion: Increased levels of HDL-c commonly observed in individuals with Type 1 diabetes may be detrimental to endothelial function when accompanied by renal dysfunction and chronic inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehz114

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC BY · PubMed Central
Figure 1 Combined effect of HDL-c levels and inflammatory burden on HDL function in adolescents with Type 1 diabetes. Data are expressed as mean ± standard deviation for NO and SO, and median (interquartile range) for PON-1. HC, healthy controls; HDL, high-density lipoprotein; NO, nitric oxide; PON-1, paraoxonase-1; SO, superoxide.
Figure 1 Combined effect of HDL-c levels and inflammatory burden on HDL function in adolescents with Type 1 diabetes. Data are expressed as mean ± standard deviation for NO and SO, and median (interquartile range) for PON-1. HC, healthy controls; HDL, high-density lipoprotein; NO, nitric oxide; PON-1, paraoxonase-1; SO, superoxide.CC BY · PubMed Central
Figure 2 Combined effect of HDL-c levels and inflammatory burden on endothelial function in adolescents with Type 1 diabetes. Linear regression model adjusted for age, sex, body mass index z-score, estimated glomerular filtration rate, and systolic blood pressure. Data are expressed as mean ± 95% confidence interval. FMD, flow-mediated dilation; HC, healthy controls; HDL, high-density lipoprotein.
Figure 2 Combined effect of HDL-c levels and inflammatory burden on endothelial function in adolescents with Type 1 diabetes. Linear regression model adjusted for age, sex, body mass index z-score, estimated glomerular filtration rate, and systolic blood pressure. Data are expressed as mean ± 95% confidence interval. FMD, flow-mediated dilation; HC, healthy controls; HDL, high-density lipoprotein.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 59

Metadata

Authors
Chiesa, S. T., Charakida, M., McLoughlin, E., Nguyen, H. C., Georgiopoulos, G., Motran, L., Elia, Y., Marcovecchio, M. L., Dunger, D. B., Dalton, R. N., Daneman, D., Sochett, E., Mahmud, F. H., & Deanfield, J. E.
Affiliations
  • University College London (GB)
  • National and Kapodistrian University of Athens (GR)
  • University of Toronto (CA)
  • University of Cambridge (GB)
  • St Thomas' Hospital (GB)
Corresponding author
Deanfield, John E
Venue
European Heart Journal
Published
2019-03-12
Volume
40
Issue
43
Pages
3559-3566
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2922106601
Cited by
54
References
42
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 7 · 2020: 12 · 2019: 3
FWCI
5.48
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Juvenile Diabetes Research Foundation
  • JDRF
  • Diabetes UK
  • DUK
  • British Heart Foundation
  • JDRF-CCTN
  • Juvenile Diabetes Research Fund—Canadian Clinical Trials Network
  • Heart and Stroke Foundation
  • Canadian Diabetes Association
  • Fondation Leducq Trans-Atlantic Network of Excellence
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
type 1 diabetes, adolescents, high-density lipoprotein, HDL dysfunction, endothelial dysfunction, systemic inflammation, early renal dysfunction, albumin-creatinine ratio, flow-mediated dilation, nitric oxide bioavailability, superoxide production, HbA1c, cardiovascular risk, glycemic control, dyslipidemia
MeSH terms
Adolescent, Child, Chronic Disease, Diabetes Mellitus, Type 1, Endothelium, Vascular, Female, Humans, Hyperlipidemias, Inflammation, Lipoproteins, HDL, Male, Biomarkers, Case-Control Studies, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation. https://app.cochat.ai/papers/10.1093/eurheartj/ehz114
The paper
Chiesa, S. T., Charakida, M., McLoughlin, E., Nguyen, H. C., Georgiopoulos, G., Motran, L., Elia, Y., Marcovecchio, M. L., Dunger, D. B., Dalton, R. N., Daneman, D., Sochett, E., Mahmud, F. H., & Deanfield, J. E. (2019). Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation. European Heart Journal. https://doi.org/10.1093/eurheartj/ehz114

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.